{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:39:44Z","timestamp":1787744384291,"version":"build-2784847793"},"reference-count":38,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Tumor necrosis factor-alpha (TNF-\u03b1) plays an important role in liver inflammation. CD40-CD40 ligand (CD40-CD40L) is a key receptor\u2013ligand signaling pair involved in the adaptive immune response and pathogenesis of autoimmune diseases. In mice, CD40 activation leads to sickness behavior syndrome (SBS) comprising weight loss, sleep disruption and depression, which can be blocked by administration of the TNF-inhibitor etanercept. In the present study, we assessed the extent of hepatic inflammation in mice devoid of the TNF-receptor 1 (TNFR1)-mediated signaling pathway. The TNFR1-depleted (TNFR1\u2212\/\u2212) adult mice and their wild type littermates were given a single intra-peritoneal injection of CD40 agonist monoclonal antibody (mAb) or rat IgG2a isotope control. As described previously, TNFR1\u2212\/\u2212 mice were protected from SBS upon CD40 mAb treatment. Cd40, tnf and tnfr1 mRNA and Tnf-\u03b1 peptide were increased in the liver of CD40 mAb-stimulated wild type mice. Serum alanine aminotransferase was elevated in both CD40-activated wild type and TNFR1\u2212\/\u2212 mice. TNFR1\u2212\/\u2212 mice showed much less intra-parenchymal infiltrates, hepatocellular necrosis, and perivascular clusters upon CD40 mAb activation than their wild type littermates. A gene expression microarray detected increased activity of metabolic and detoxification pathways and decreased activity of inflammatory pathways. We conclude that immune activation and development of liver inflammation in CD40L interactions depend on TNFR1-mediated signaling pathways and are counteracted by alterations in metabolic pathways.<\/jats:p>","DOI":"10.3390\/biomedicines9080863","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T22:06:48Z","timestamp":1626991608000},"page":"863","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CD40 Agonist Monoclonal Antibody-Mediated Hepatitis in TNF-Receptor 1 Gene Knockout Mice"],"prefix":"10.3390","volume":"9","author":[{"given":"Oksana","family":"Raabe","sequence":"first","affiliation":[{"name":"Department of Biomedicine, University of Basel, 4056 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Birchler","sequence":"additional","affiliation":[{"name":"Institute of Experimental Immunology, University of Zurich, 8057 Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7612-9394","authenticated-orcid":false,"given":"Hubert","family":"Rehrauer","sequence":"additional","affiliation":[{"name":"Functional Genomics Center Zurich (FGCZ), ETH Z\u00fcrich, University of Zurich, 8057 Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Eppler","sequence":"additional","affiliation":[{"name":"Institute of Anatomy, University of Z\u00fcrich, 8057 Z\u00fcrich, Switzerland"},{"name":"Institute of Anatomy, University of Bern, 3012 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.smim.2009.05.008","article-title":"Functional roles for T cell CD40 in infection and autoimmune disease: The role of CD40 in lymphocyte homeostasis","volume":"21","author":"Munroe","year":"2009","journal-title":"Semin. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.smim.2009.05.012","article-title":"CD40 and autoimmunity: The dark side of a great activator","volume":"21","author":"Peters","year":"2009","journal-title":"Semin. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","article-title":"Molecular mechanism and function of CD40\/CD40L engagement in the immune system","volume":"229","author":"Elgueta","year":"2009","journal-title":"Immunol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Djureinovic, D., Wang, M., and Kluger, H.M. (2021). Agonistic CD40 Antibodies in Cancer Treatment. Cancers, 13.","DOI":"10.3390\/cancers13061302"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"107709","DOI":"10.1016\/j.pharmthera.2020.107709","article-title":"Molecular basis and therapeutic implications of CD40\/CD40L immune checkpoint","volume":"219","author":"Tang","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/7854_2016_7","article-title":"Depression in autoimmune diseases","volume":"31","author":"Pryce","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"ref_7","unstructured":"Vial, G., Gensous, N., and Duffau, P. (2021). The CD40-CD40L axis: Current and future implications in clinical immunology. Rev. Med. Interne, 2."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/hep.20802","article-title":"CD154-CD40 interactions drive hepatocyte apoptosis in murine fulminant hepatitis","volume":"42","author":"Zhou","year":"2005","journal-title":"Hepatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"786","DOI":"10.2353\/ajpath.2006.050314","article-title":"Pathogenic role of B cells in anti-CD40-induced necroinflammatory liver disease","volume":"168","author":"Kimura","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/biof.62","article-title":"CD40\/CD40L signaling and its implication in health and disease","volume":"35","author":"Chatzigeorgiou","year":"2009","journal-title":"Biofactors"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1200\/JCO.2008.21.3017","article-title":"Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin\u2019s lymphoma","volume":"27","author":"Advani","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/10428190903440946","article-title":"A phase I study of dacetuzumab (SGN-40, a humanized anti-CD40 monoclonal antibody) in patients with chronic lymphocytic leukemia","volume":"51","author":"Furman","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/10428194.2012.710328","article-title":"Pilot study of dacetuzumab in combination with rituximab and gemcitabine for relapsed or refractory diffuse large B-cell lymphoma","volume":"54","author":"Bartlett","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"De Vos, S., Forero-Torres, A., Ansell, S.M., Kahl, B., Cheson, B.D., Bartlett, N.L., Furman, R.R., Winter, J.N., Kaplan, H., and Timmerman, J. (2014). A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors. J. Hematol. Oncol., 44.","DOI":"10.1186\/1756-8722-7-44"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1158\/1078-0432.CCR-12-2064","article-title":"Agonistic CD40 antibodies and cancer therapy","volume":"19","author":"Vonderheide","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e23033","DOI":"10.4161\/onci.23033","article-title":"Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors","volume":"2","author":"Vonderheide","year":"2013","journal-title":"Oncoimmunology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e001153","DOI":"10.1136\/jitc-2020-001153","article-title":"Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients","volume":"8","author":"Machiels","year":"2020","journal-title":"J. Immunother Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000079408","article-title":"A cytokine-based neuroimmunologic mechanism of cancer-related symptoms","volume":"11","author":"Lee","year":"2004","journal-title":"Neuroimmunomodulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0165-5728(03)00075-4","article-title":"The EAE-associated behavioral syndrome: I. Temporal correlation with inflammatory mediators","volume":"137","author":"Pollak","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.bbi.2010.11.001","article-title":"TNFR1 is essential for CD40, but not for lipopolysaccharide-induced sickness behavior and clock gene dysregulation","volume":"25","author":"Taraborrelli","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbi.2012.10.004","article-title":"CD40 activation induces NREM sleep and modulates genes associated with sleep homeost asis","volume":"27","author":"Gast","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbi.2015.06.184","article-title":"Pryce CR8 CD40-TNF activation in mice induces extended sickness behavior syndrome co-incident with but not dependent on activation of the kynurenine pathway","volume":"50","author":"Cathomas","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000282062","article-title":"The role of chemokines in the recruitment of lymphocytes to the liver","volume":"28","author":"Oo","year":"2010","journal-title":"Dig. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1158\/2326-6066.CIR-14-0182","article-title":"Systemic agonistic anti-cd40 treatment of tumor-bearing mice modulates hepatic myeloid-suppressive cells and causes immune-mediated liver damage","volume":"3","author":"Ma","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1182\/bloodadvances.2020001624","article-title":"Line-selective macrophage activation with an anti-CD40 antibody drives a hemophagocytic syndrome in mice","volume":"4","author":"Ingoglia","year":"2020","journal-title":"Blood Adv."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbi.2015.02.027","article-title":"Neutralization of colony-stimulating factor 1 receptor prevents sickness behavior syndrome by reprogramming inflammatory monocytes to produce IL-10","volume":"48","author":"Strauss","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1074-7613(00)80258-7","article-title":"The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching","volume":"5","author":"Rolink","year":"1996","journal-title":"Immunity"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/0748730409336579","article-title":"Clock gene modulation by TNF-alpha depends on calcium and p38 MAP kinase signaling","volume":"24","author":"Petrzilka","year":"2009","journal-title":"J. Biol. Rhythms"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"12843","DOI":"10.1073\/pnas.0701466104","article-title":"TNF-alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription","volume":"104","author":"Cavadini","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","unstructured":"(2021, May 07). Available online: https:\/\/www.bioconductor.org."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"ClusterProfiler: An R package for comparing biological themes among gene clusters","volume":"16","author":"Guangchuang","year":"2012","journal-title":"OMICS J. Integr. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Zhang, S., Breidenbach, J.D., Russell, B.H., George, J., and Haller, S.T. (2020). CD40\/CD40L Signaling as a Promising Therapeutic Target for the Treatment of Renal Disease. J. Clin. Med., 9.","DOI":"10.3390\/jcm9113653"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00418-009-0577-1","article-title":"Cellular organization of normal mouse liver: A histological, quantitative immunocytochemical, and fine structural analysis","volume":"131","author":"Baratta","year":"2009","journal-title":"Histochem. Cell Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1074-7613(00)80588-9","article-title":"Lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues","volume":"9","author":"Mink","year":"1998","journal-title":"Immunity"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/cei.12193","article-title":"Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis","volume":"174","author":"Tanaka","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bbi.2016.08.001","article-title":"Differential effects of peripheral and brain tumor necrosis factor on inflammation, sickness, emotional behavior and memory in mice","volume":"58","author":"Klaus","year":"2016","journal-title":"Brain Behav. Immun"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"14702","DOI":"10.1038\/s41598-019-50976-6","article-title":"Depletion of CD40 on CD11c+ cells worsens the metabolic syndrome and ameliorates hepatic inflammation during NASH","volume":"9","author":"Aarts","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Bojadzic, D., Chen, J., Alcazar, O., and Buchwald, P. (2018). Design, Synthesis, and Evaluation of Novel Immunomodulatory Small Molecules Targeting the CD40\u2013CD154 Costimulatory Protein-Protein Interaction. Molecules, 23.","DOI":"10.3390\/molecules23051153"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/8\/863\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:33:26Z","timestamp":1760164406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/8\/863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["biomedicines9080863"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9080863","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,22]]}}}